DeepMed Research

CENTRE ANTOINE LACASSAGNE

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 1961-01-01

Employees: -

Market Cap: -

Website: http://www.centreantoinelacassagne.org/fr

Clinical Trials

Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma

Phase 3

Active, not recruiting

Conditions: Rectal Neoplasms

Interventions: Radiation: 3D conformal EBRT
Device: Contact X-ray brachytherapy 50 kV
Drug: Capecitabine

First Posted Date: 2015-07-22

Last Posted Date: 2024-08-28

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 236

Registration Number: NCT02505750

Locations: 🇫🇷
Centre d'oncologie et de radiothérapie Mâcon, Mâcon, France
🇩🇰
Aarhus University Hospital, Aarhus, Denmark
🇫🇷
Hospices Civils de Lyon - Hôpital de la Croix Rousse, Lyon, France

and more 17 locations

Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient

Phase 1

Completed

Conditions: Safety
Clinical Efficacy

Interventions: Drug: Adcetris-Levact

First Posted Date: 2015-06-10

Last Posted Date: 2023-01-04

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 60

Registration Number: NCT02467946

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 1

Recruiting

Conditions: Glioblastoma Multiforme

Interventions: Drug: Pazopanib

First Posted Date: 2015-01-06

Last Posted Date: 2025-05-20

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 51

Registration Number: NCT02331498

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, Cedex 2, France

Single Fraction Early Prostate Irradiation (SiFEPI)

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Radiation: exclusive single-fraction irradiation

First Posted Date: 2014-04-04

Last Posted Date: 2021-10-06

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 35

Registration Number: NCT02104362

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)

Not Applicable

Completed

Conditions: Glioma
Cerebral Metastases

Interventions: Other: PET 18FDOPA

First Posted Date: 2013-12-30

Last Posted Date: 2016-07-26

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 85

Registration Number: NCT02022800

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Impact of a Telephonic Monitoring During Inter-treatment Intervals on Emotional State, Quality of Life and Toxicities, on Neo Adjuvant or Adjuvant Chemotherapy-treated Patients

Not Applicable

Completed

Conditions: Patients Undergoing Adjuvant Chemotherapy
Non-metastatic Patients With Breast Cancer
Non-metastatic Patients With Colon Cancer
Non-metastatic Patients With Rectal Cancer

Interventions: Other: Clinical and psychosocial phone calls

First Posted Date: 2013-11-06

Last Posted Date: 2019-07-23

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 274

Registration Number: NCT01977053

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, Cedex 2, France
🇫🇷
Polyclinique St Jean, Cagnes sur Mer, France

Prospective Evaluation of Iron Status in Cancer Patients Beginning Chemotherapy

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Iron status follow up

First Posted Date: 2013-10-24

Last Posted Date: 2016-07-26

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 480

Registration Number: NCT01968304

Locations: 🇫🇷
Centre Antoine LACASSAGNE, Nice, France

Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Not Applicable

Completed

Conditions: Pharmacogenetic Study

Interventions: Drug: Abiraterone Acetate

First Posted Date: 2013-05-21

Last Posted Date: 2020-12-04

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 148

Registration Number: NCT01858441

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer

Phase 2

Completed

Conditions: Prostatic Neoplasms

Interventions: Drug: Placebo
Drug: METFORMIN
Drug: TAXOTERE®

First Posted Date: 2013-02-21

Last Posted Date: 2018-06-06

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 100

Registration Number: NCT01796028

Locations: 🇫🇷
Centre ANTOINE LACASSAGNE, Nice, France

Single Fraction Elderly Breast Irradiation (SiFEBI)

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Radiation: IPAS

First Posted Date: 2012-11-15

Last Posted Date: 2021-12-17

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 37

Registration Number: NCT01727011

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy